127 related articles for article (PubMed ID: 9840606)
21. Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities.
Collins RC; Gonzales-Peralta C; Castro J; Zea-Flores G; Cupp MS; Richards FO; Cupp EW
Am J Trop Med Hyg; 1992 Aug; 47(2):156-69. PubMed ID: 1503185
[TBL] [Abstract][Full Text] [Related]
22. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.
Awadzi K; Boakye DA; Edwards G; Opoku NO; Attah SK; Osei-Atweneboana MY; Lazdins-Helds JK; Ardrey AE; Addy ET; Quartey BT; Ahmed K; Boatin BA; Soumbey-Alley EW
Ann Trop Med Parasitol; 2004 Apr; 98(3):231-49. PubMed ID: 15119969
[TBL] [Abstract][Full Text] [Related]
23. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
Cupp EW; Cupp MS
Am J Trop Med Hyg; 2005 Dec; 73(6):1159-61. PubMed ID: 16354830
[TBL] [Abstract][Full Text] [Related]
24. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
Awadzi K; Dadzie KY; Shulz-Key H; Haddock DR; Gilles HM; Aziz MA
Ann Trop Med Parasitol; 1985 Feb; 79(1):63-78. PubMed ID: 3838638
[TBL] [Abstract][Full Text] [Related]
25. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT
Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872
[TBL] [Abstract][Full Text] [Related]
26. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
[TBL] [Abstract][Full Text] [Related]
27. Maintaining compliance to ivermectin in communities in two West African countries.
Whitworth JA; Alexander ND; Seed P; Thomas W; Abiose A; Jones BR
Health Policy Plan; 1996 Sep; 11(3):299-307. PubMed ID: 10160375
[TBL] [Abstract][Full Text] [Related]
28. Ivermectin treatment in severe asymmetric reactive onchodermatitis (sowda) in Sudan.
Baraka OZ; Mahmoud BM; Ali MM; Ali MH; el Sheikh EA; Homeida MM; Mackenzie CD; Williams JF
Trans R Soc Trop Med Hyg; 1995; 89(3):312-5. PubMed ID: 7660447
[TBL] [Abstract][Full Text] [Related]
29. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
30. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Greene BM; Taylor HR; Cupp EW; Murphy RP; White AT; Aziz MA; Schulz-Key H; D'Anna SA; Newland HS; Goldschmidt LP
N Engl J Med; 1985 Jul; 313(3):133-8. PubMed ID: 3892293
[TBL] [Abstract][Full Text] [Related]
31. Safety of and compliance with community-based ivermectin therapy.
Pacqué M; Muñoz B; Greene BM; White AT; Dukuly Z; Taylor HR
Lancet; 1990 Jun; 335(8702):1377-80. PubMed ID: 1971669
[TBL] [Abstract][Full Text] [Related]
32. Improvement in severe onchocercal skin disease after a single dose of ivermectin.
Pacqué M; Elmets C; Dukuly ZD; Muñoz B; White AT; Taylor HR; Greene BM
Am J Med; 1991 May; 90(5):590-4. PubMed ID: 2029016
[TBL] [Abstract][Full Text] [Related]
33. An improved dosing schedule for ivermectin as a microfilaricidal agent against onchocerciasis.
Shu EN; Okonkwo PO; Ogbodo SO
Acta Trop; 1997 Dec; 68(3):269-75. PubMed ID: 9492911
[TBL] [Abstract][Full Text] [Related]
34. Decrease in adverse reactions after repeated ivermectin treatment in onchocerciasis.
Van der Lelij A; Rothova A; Klaassen-Broekema N; Wilson WR; Barbe RF; Stilma JS
Doc Ophthalmol; 1990 Oct; 75(3-4):215-24. PubMed ID: 2090395
[TBL] [Abstract][Full Text] [Related]
35. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
[TBL] [Abstract][Full Text] [Related]
36. [Onchocerciasis].
Enk CD; Gardlo K; Ruzicka T; BenEzra D
Hautarzt; 2003 Jun; 54(6):513-7. PubMed ID: 12759735
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of onchocerciasis control in the Upper Denkyira East municipal in the forest area of Ghana: Responses of participants and distributors to the CDTI programme.
Agyemang ANO; Badu K; Baffour-Awuah S; Owusu-Dabo E; Biritwum NK; Garms R; Kruppa TF
Acta Trop; 2018 Sep; 185():357-362. PubMed ID: 29932933
[TBL] [Abstract][Full Text] [Related]
38. Ivermectin--clinical trials and treatment schedules in onchocerciasis.
Brown KR; Neu DC
Acta Leiden; 1990; 59(1-2):169-75. PubMed ID: 2198749
[TBL] [Abstract][Full Text] [Related]
39. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
40. Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment.
Hoerauf A; Mand S; Adjei O; Fleischer B; Büttner DW
Lancet; 2001 May; 357(9266):1415-6. PubMed ID: 11356444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
